BEUDAMED
    10,000 results · 86ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Regulation: Us FDA ×

    GEL-ONE X-LINKED HYALUR 3ML

    FDA Adverse Event
    Injury ·SEIKAGAKU CORPORATION·Product code MOZ·March 20, 2022

    GEL-ONE X-LINKED HYALUR 3ML

    FDA Adverse Event
    Injury ·ZIMMER BIOMET, INC.·Product code MOZ·July 12, 2021

    GEL-ONE X-LINKED HYALUR 3ML

    FDA Adverse Event
    Injury ·SEIKAGAKU CORPORATION·Product code MOZ·July 13, 2021

    Synvisc-One (hylan G-F 20), 6mL delivered from a 10mL syringe Product Usage: A elastoviscous high molecular weight fluid containing hylan A and hylan B polymers produced from chicken combs. Synvisc-One is administered as a single intra-articular injection. Synvisc-One is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen.

    FDA Recall
    Terminated ·Sanofi Genzyme·Product code MOZ·December 11, 2017

    Euflexxa (1% sodium hyaluronate). Pre-filled syringe, Rx only, 3 syringes per carton; Manufactured by Ferring Pharmaceuticals In, Parsippany, NJ 07054; Manufactured by Bio-Technology General (Israel Ltd. Be er Tuvia, Kiryat Malachi 83104 Israel. Indicated for the treatment of pain in osteoarthritis of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics.

    FDA Recall
    Terminated ·Ferring Pharmaceuticals Inc·Product code MOZ·April 16, 2010

    Acid, Hyaluronic, Intraarticular

    FDA classification
    FDA Class 3 ·Acid, Hyaluronic, Intraarticular

    EUFLEXXA

    FDA Adverse Event
    Injury ·BIO-TECHNOLOGY GENERAL (ISRAEL) LTD·Product code MOZ·December 2, 2016

    SYNVISC

    FDA Adverse Event
    Injury ·SANOFI.AVENTIS / GENCYME CORP.·Product code MOZ·October 12, 2016

    EUFLEXXA INJ 10MG/ML

    FDA Adverse Event
    Injury ·UNK·Product code MOZ·December 19, 2016

    ORTHOVISC

    FDA Adverse Event
    Injury ·ANIKA THERAPEUTICS INC.·Product code MOZ·November 30, 2016

    HYALGAN

    FDA Adverse Event
    Injury ·FIDIA FARMACEUTICI S.P.A.·Product code MOZ·October 10, 2016

    SYNVISC

    FDA Adverse Event
    Injury ·GENZYME CORPORATION(RIDGEFIELD)·Product code MOZ·November 10, 2016

    SYNVISC ONE

    FDA Adverse Event
    Injury ·GENZYME BIOSURGERY (RIDGEFIELD)·Product code MOZ·November 10, 2016

    SYNVISC ONE INJ 8MG/ML

    FDA Adverse Event
    Injury ·UNK·Product code MOZ·December 9, 2016

    SYNVISC ONE (SYNVISC ONE)

    FDA Adverse Event
    Injury ·GENZYME BIOSURGERY (RIDGEFIELD)·Product code MOZ·November 14, 2016

    EUFLEXXA

    FDA Adverse Event
    Injury ·BIO-TECHNOLOGY GENERAL (ISRAEL) LTD·Product code MOZ·November 22, 2016

    SYNVISC ONE INJ 8MG/ML

    FDA Adverse Event
    Injury ·GENZYME·Product code MOZ·December 20, 2016

    SYNVISC

    FDA Adverse Event
    Injury ·GENZYME BIOSURGERY (RIDGEFIELD)·Product code MOZ·October 21, 2016

    SYNVISC 16MG/2ML

    FDA Adverse Event
    Injury ·SANOFI-AVENTIS·Product code MOZ·August 25, 2015

    SYNVISC (SYNVISC)

    FDA Adverse Event
    Injury ·GENZYME BIOSURGERY (RIDGEFIELD)·Product code MOZ·August 4, 2015